ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Every earnings call announcement on NSE and BSE that our alert engine sent, newest first. Each one has its own page with the summary, the key figures and the original filing.
Time
9,412 announcements with these filters
Q2 FY27 consolidated revenue ₹1,804 cr (+120.5% YoY), EBITDA ₹154.7 cr (8.6% margin), PAT ₹61.2 cr. Punjab plant ramp-up drove volumes.
Joint Gateway-Snowman call. Snowman pallets stored up ~10% YoY, but warehousing margins sit near 10-11% and 5PL barely grew (1-2%). Management hedged on the ₹100 Cr EBITDA target.
Revenue ₹21.3 Cr, +1.1% QoQ; EBITDA -₹5.9 Cr, PAT -₹4.1 Cr. Management leans on India run-rate and playbook narrative; flat top line since 2023 is not directly answered.
Q2 EBITDA more than doubled to ₹22 Cr on occupancy gains; ADR flat near 3%. Net debt cut to ₹31 Cr after ₹30 Cr repayment. H2 acceleration asserted, never quantified.
Q2FY27 revenue ₹316 Cr (+30% YoY), EBITDA ₹68 Cr at 21% margin, PAT ₹40 Cr (+57%). Strategy: backward integration, high-value APIs, DMF/CEP filings, ₹280 Cr capex.
H1 FY27 revenue Rs 314.6 cr (+11%); record Q2 revenue Rs 189.3 cr (+16%). H1 PAT Rs 29.6 cr (+18%). Debt-free; Mufti 2.0 premiumisation drives strategy.
Record Q2 revenue of ₹295 Cr (+25%) and PAT up 97% to ₹10 Cr, but margin pressure and rising net debt. No FY28 guidance given.
Q2 FY27 revenue nil versus ₹325.19 lakh a year ago; Q2 PAT loss ₹52.79 lakh. H1 FY27 revenue ₹64.90 lakh, PAT loss ₹110.15 lakh. Strategy: Sankalp EPC, HETL stake, solar and EV bids.
Q2 revenue rose 15.8%, EBITDA 60% and PAT 90% YoY, but management gave no forward growth numbers despite calling the outlook 'quite bullish'. Government revenue fell on a prior one-off, and receivable days stayed near 120-122.
Q2FY27 consolidated operating revenue ₹557cr (+1.5%); PAT ₹97cr (-11.0%) on export collapse and revenue-mix shift. Order book ₹9,388cr.
H1 FY27 consolidated revenue from operations ₹2,999 Cr (+48% YoY), attributable PAT ₹1,683 Cr (+53%), EBITDA margin 67%. No explicit guidance; growth driven by transaction charges.
Q2 FY27 revenue Rs138.2 Cr (+44.7% YoY), H1 Rs239.0 Cr (+35.4%). EBITDA margin compressed to 18.4% on POY cost spike; 384-loom expansion underway.
Q2 FY27 ex-residential revenue ₹5,110mn (+10.7%), EBITDA ₹2,274mn (+13.5%, 45% margin). Reported PAT ₹2,163mn (+39.7%) includes ₹1,125mn one-time tax credit. Hospitality RevPAR +7.2%.
Consolidated Q2 revenue rose 29% YoY to ₹2,779 Cr, but EBITDA margin compressed to about 5.5% from 6.1%, so profit growth lagged sales.
Consolidated revenue rose 9.8%, but EBITDA grew only 0.8% and margin fell 130 bps to 14.6%. PAT was flat at ₹7.9 Cr. Standalone hospitals carry profit while subsidiaries drag. Management deflected on Mumbai, MedTech expansion and POSO revenue.
Standalone Q2 FY27 revenue rose 18.24% to ₹129.78 Cr and PAT rose 45.75% to ₹6.94 Cr. Same-store sales slowed from Q1, and delivery mix rose sharply, so growth leans on delivery and new openings.
Q2 FY27 revenue of about ₹1,576 Cr and EBITDA of ₹207 Cr, with margin down to 13.2% from 13.9%. Cash conversion and working capital improved, but monsoon and polymer headwinds persist. H2 is guided flattish.
Q2 FY27 standalone revenue ₹6,971L (+27.2% YoY), EBITDA ₹906L (13.0% margin), PAT ₹483L (+35.3%). H1 revenue +25.0%, PAT +52.3%. Borrowings cut 23% to ₹2,149L.
Q2 FY27 revenue ₹56.1 cr (-38% YoY) and PAT loss ₹77.5 cr, including ₹68 cr exceptional items. H1 revenue ₹159.9 cr (-10%). Transitioning to an independent branded pharma model; Minipress XL acquired.
Q2 revenue hit a record ₹501 Cr and H1 rose 19% to ₹867 Cr, but profit rose only 2% and operating cash flow turned negative. Working capital is about 60 days against a 40–45 day guidance, and steel cost pass-through lagged.
Revenue strong (Q2 +33.6%, H1 +40.3%), but Q2 PAT grew only 7.7% as costs, forex and freight squeezed margins; margin recovery is asserted without numbers.
Management skipped detailed numbers and gave no guidance. Ratings revenue grew 15.2% in H1, non-ratings stayed flat near ₹80 Cr a quarter, and acquisition losses were left unresolved.
Q2 revenue rose 63% YoY to ~₹110 Cr with a 20.4% EBITDA margin, but FY27 guidance was only 'hopeful', and the negative operating cash flow and receivables question went unanswered.
Standalone Q2 revenue rose 8% to ₹290 Cr and PAT rose 2% to ₹120 Cr on 12% volume growth. The company is debt-free, but H1 EBITDA was flat, subsidiary losses persist, and the tariff path remains unresolved.
Q2FY27: revenue ₹55.36 Cr (+14.8% YoY), EBITDA ₹10.78 Cr (19.5% margin), PAT ₹2.18 Cr. Barista, Kylin and Drizzle & Dust all grew; network at 569 stores.
Q2 FY27 record: revenue INR17,103 Cr (+44%), EBITDA INR2,219 Cr (+47%), PAT INR1,377 Cr (+52%). Board approved demerger of consumer finance undertaking.
Q2 FY27 revenue rose 53% YoY to ~₹40 Cr and PAT rose 55% to ₹8.49 Cr, but EBITDA margin slipped to 38.65% on mix. Growth relies on capacity expansion and rising debt (₹65–70 Cr).
Q2 FY27 revenue ₹2,872 Mn rose 35% YoY, but EBITDA margin fell to 7.6% from 12.1% and PAT dropped 26% YoY. H1 PAT rose 38%.
Q2 FY27 consolidated revenue ₹1,259 Mn (+50.7% YoY), EBITDA ₹166 Mn (+34.5%), PAT ₹128 Mn (+25.5%); input-cost pressure cut standalone margins.
Q2 revenue ₹176.69 Cr (~47% YoY) and PAT ₹9.52 Cr (+62%), helped by lower forex loss. Margins remain thin, and management deferred value-ramp and margin timing.